VASH1 anticorps (AA 3-100)
Aperçu rapide pour VASH1 anticorps (AA 3-100) (ABIN524800)
Antigène
Voir toutes VASH1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 3-100
-
Fonction
- Mouse monoclonal antibody raised against a partial recombinant VASH1.
-
Séquence
- GGKKVAGGGS SGATPTSAAA TAPSGVRRLE TSEGTSAQRD EEPEEEGEED LRDGGVPFFV NRGGLPVDEA TWERMWKHVA KIHPDGEKVA QRIRGATD
-
Réactivité croisée
- Humain
-
Attributs du produit
- Antibody Reactive Against Recombinant Protein.
-
Immunogène
- VASH1 (NP_055724, 3 a.a. ~ 100 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
-
Isotype
- IgG2a
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- In 1x PBS, pH 7.4
-
Conseil sur la manipulation
- Aliquot to avoid repeated freezing and thawing.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
: "Keratin 19 as a key molecule in progression of human hepatocellular carcinomas through invasion and angiogenesis." dans: BMC cancer, Vol. 16, Issue 1, pp. 903, (2016) (PubMed).
: "Vasohibin-1 increases the malignant potential of colorectal cancer and is a biomarker of poor prognosis." dans: Anticancer research, Vol. 34, Issue 10, pp. 5321-9, (2014) (PubMed).
: "Upregulation of vasohibin-1 expression with angiogenesis and poor prognosis of hepatocellular carcinoma after curative surgery." dans: Medical oncology (Northwood, London, England), Vol. 29, Issue 4, pp. 2727-36, (2012) (PubMed).
-
: "Keratin 19 as a key molecule in progression of human hepatocellular carcinomas through invasion and angiogenesis." dans: BMC cancer, Vol. 16, Issue 1, pp. 903, (2016) (PubMed).
-
- VASH1 (Vasohibin 1 (VASH1))
-
Autre désignation
- VASH1
-
Sujet
-
Full Gene Name: vasohibin 1
Synonyms: KIAA1036 -
ID gène
- 22846
-
NCBI Accession
- NM_014909
Antigène
-